Anti-Ri antibody positive opsoclonusmyoclonus in a male patient with breast carcinoma

Journal of Neurology

Volumn 249, Issue 12, 2002, Pages 1710-1712

  Wirtz, Paul W ^b   Sillevis Smitt, Peter A E ^a   Hoff, Jorrit I ^b   De Leeuw, Bertie ^a   Jan Lammers, Gert ^b   Van Duinen, Sjoerd G ^b   Verschuuren, Jan J ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anti Ri; Breast carcinoma; Opsoclonusmyoclonus ataxia

Indexed keywords

ANTIBODY; ANTIGEN; NOVA 1 ANTIGEN; NOVA 2 ANTIGEN; RI ANTIBODY; UNCLASSIFIED DRUG;

AGED; ANTIBODY BLOOD LEVEL; ANXIETY DISORDER; ARTICLE; ATAXIA; BEHAVIOR DISORDER; BREAST CARCINOMA; CASE REPORT; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; HUMAN; IMMUNE RESPONSE; MALE; MYOCLONUS; OPSOCLONUS; PRIORITY JOURNAL; STARTLE REFLEX;

AGED; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; BREAST NEOPLASMS, MALE; HUMANS; MALE; NERVE TISSUE PROTEINS; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; RNA-BINDING PROTEINS;

EID: 0344838638     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-002-0913-z     Document Type: Article

References (17)

1. Anderson NE, Budde-Steffen C, Rosenblum MK, Graus F, Ford D, Synek BJ, Posner JB (1988) Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome. Medicine 67: 100-109
2. Bataller L, Graus F, Saiz A, Vilchez JJ (2001) Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain 124:437-443
3. Brashear R, Li L, Herr JC (1992) Anti-neuronal antibody in two patients with paraneoplastic opsoclonus-ataxia. Neurology 42(Suppl 3):457
4. Buckanovich RJ, Darnell RB (1997) The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo. Mol Cell Biol 17:3194-3201
5. Casado JL, Gil-Peralta A, Graus F, Arenas C, Lopez JM, Alberca R (1994) Anti-Ri antibodies associated with opsoclonus and progressive encephalomyelitis with rigidity. Neurology 44:1521-1522
6. Digre KB (1986) Opsoclonus in adults. Report of three cases and review of the literature. Arch Neurol 43:1165-1175
7. Escudero D, Barnadas A, Codina M, Fueyo J, Graus F (1993) Anti-Ri-associated paraneoplastic neurologic disorder without opsoclonus in a patient with breast cancer. Neurology 43:1605-1606
8. Hormigo A, Dalmau J, Rosenblum MK, River ME, Posner JB (1994) Immunological and pathological study of anti-Ri-associated encephalopathy. Ann Neurol 36:896-902
9. Jensen KB, Dredge BK, Stefani G, Zhong R, Buckanovich RJ, Okano HJ, Yang YY, Darnell RB (2000) Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability. Neuron 25:359-371
10. Jongen JL, Moll WJ, Sillevis Smitt PA, Vecht CJ, Tijssen CC (1998) Anti-Ri positive opsoclonus-myoclonus-ataxia in ovarian duct cancer. J Neurol 245: 691-692
11. Kikuchi H, Yamada T, Okayama A, Hara H, Taniwaki T, Shigeto H, Sasaki M, Iwaki T, Kira J (2000) Anti-Ri-associated paraneoplastic cerebellar degeneration without opsoclonus in a patient with a neuroendocrine carcinoma of the stomach. Fukuoka Igaku Zasshi 91:104-109
12. Luque FA, Furneaux HM, Ferziger R, Rosenblum MK, Wray SH, Schold SC Jr, Glantz MJ, Jaeckle KA, Biran H, Lesser M (1991) Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol 29: 241-251
13. Pranzatelli MR (1992). The neurobiology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol 15: 186-228
14. Prestigiacomo CJ, Balmaceda C, Dalmau J (2001) Anti-Ri-associated paraneoplastic opsoclonus-ataxia syndrome in a man with transitional cell carcinoma. Cancer 91:1423-1428
15. Ridley A, Kennard C, Scholtz CL, Buttner-Ennever JA, Summers B, Turnbull A (1987) Omnipause neurons in two cases of opsoclonus associated with oat cell carcinoma of the lung. Brain 110:1699-1709
16. Shiang R, Ryan SG, Zhu YZ, Hahn AF, O'Connell P, Wasmuth JJ (1993) Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nat Genet 5:351-358
17. Yang YY, Yin GL, Darnell RB (1998) The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. Proc Natl Acad Sci USA 95:13254-13259